1 Kris-Etherton, PM, Harris, WS & Appel, LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
2 Lichtenstein, AH, Appel, LJ, Brands, M, et al. (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82–96.
3 Lavie, CJ, Milani, RV, Mehra, MR, et al. (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54, 585–594.
4 Mente, A, de Koning, L, Shannon, HS, et al. (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169, 659–669.
5 Riediger, ND, Othman, RA, Suh, M, et al. (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109, 668–679.
6 Filion, KB, El Khoury, F, Bielinski, M, et al. (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 10, 24.
7 Jadad, AR, Moore, RA, Carroll, D, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17, 1–12.
8 Dehmer, GJ, Popma, JJ, van den Berg, EK, et al. (1988) Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319, 733–740.
9 Nye, ER, Ablett, MB, Robertson, MC, et al. (1990) Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z J Med 20, 549–552.
10 Bairati, I, Roy, L & Meyer, F (1992) Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85, 950–956.
11 Leaf, A, Jorgensen, MB, Jacobs, AK, et al. (1994) Do fish oils prevent restenosis after coronary angioplasty? Circulation 90, 2248–2257.
12 Sacks, FM, Stone, PH, Gibson, CM, et al. (1995) Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 25, 1492–1498.
13 Eritsland, J, Arnesen, H, Gronseth, K, et al. (1996) Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 77, 31–36.
14 Leng, GC, Lee, AJ, Fowkes, FG, et al. (1998) Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr 17, 265–271.
16 Johansen, O, Brekke, M, Seljeflot, I, et al. (1999) N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 33, 1619–1626.
17 von Schacky, C, Angerer, P, Kothny, W, et al. (1999) The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130, 554–562.
18 Nilsen, DW, Albrektsen, G, Landmark, K, et al. (2001) Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 74, 50–56.
19 Burr, ML, Ashfield-Watt, PA, Dunstan, FD, et al. (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57, 193–200.
20 Leaf, A, Albert, CM, Josephson, M, et al. (2005) Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112, 2762–2768.
21 Raitt, MH, Connor, WE, Morris, C, et al. (2005) Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293, 2884–2891.
22 Brouwer, IA, Zock, PL, Camm, AJ, et al. (2006) Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295, 2613–2619.
23 Yokoyama, M, Origasa, H, Matsuzaki, M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090–1098.
24 Gissi, HFI, Tavazzi, L, Maggioni, AP, et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223–1230.
25 Einvik, G, Klemsdal, TO, Sandvik, L, et al. (2010) A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil 17, 588–592.
26 Galan, P, Kesse-Guyot, E, Czernichow, S, et al. (2010) Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 341, c6273.
27 Rauch, B, Schiele, R, Schneider, S, et al. (2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122, 2152–2159.
28 Nodari, S, Triggiani, M, Campia, U, et al. (2011) Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 57, 870–879.
29 Kromhout, D, Giltay, EJ, Geleijnse, JM, et al. (2010) n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363, 2015–2026.
30 von Schacky, C & Harris, WS (2007) Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73, 310–315.
31 Mozaffarian, D (2008) Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 87, 1991S–1996S.
32 Marik, PE & Varon, J (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 32, 365–372.
33 Saravanan, P, Davidson, NC, Schmidt, EB, et al. (2010) Cardiovascular effects of marine omega-3 fatty acids. Lancet 376, 540–550.
34 Singh, RB, Niaz, MA, Sharma, JP, et al. (1997) Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival–4. Cardiovasc Drugs Ther 11, 485–491.
35 Horton, R (2005) Expression of concern: Indo-Mediterranean Diet Heart Study. Lancet 366, 354–356.
36 White, C (2005) Suspected research fraud: difficulties of getting at the truth. BMJ 331, 281–288.
37 Iso, H, Kobayashi, M, Ishihara, J, et al. (2006) Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113, 195–202.
38 Watanabe, N, Watanabe, Y, Kumagai, M, et al. (2009) Administration of dietary fish oil capsules in healthy middle-aged Japanese men with a high level of fish consumption. Int J Food Sci Nutr 60, Suppl. 5, 136–142.
39 Origasa, H, Yokoyama, M, Matsuzaki, M, et al. (2010) Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia. Circ J 74, 510–517.
40 Mozaffarian, D (2007) Fish, n-3 fatty acids, and cardiovascular haemodynamics. J Cardiovasc Med (Hagerstown) 8, Suppl. 1, S23–S26.
41 Perez-Martinez, P, Delgado-Lista, J, Perez-Jimenez, F, et al. (2010) Update on genetics of postprandial lipemia. Atheroscler Suppl 11, 39–43.
42 Teslovich, TM, Musunuru, K, Smith, AV, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713.
43 Pishva, H, Mahboob, SA, Mehdipour, P, et al. (2010) Fatty acid-binding protein-2 genotype influences lipid and lipoprotein response to eicosapentaenoic acid supplementation in hypertriglyceridemic subjects. Nutrition 26, 1117–1121.
44 Olano-Martin, E, Anil, E, Caslake, MJ, et al. (2010) Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 209, 104–110.
45 Caslake, MJ, Miles, EA, Kofler, BM, et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 88, 618–629.
46 Mozaffarian, D & Rimm, EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885–1899.
47 Thies, F, Garry, JM, Yaqoob, P, et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477–485.
48 Harris, WS, Miller, M, Tighe, AP, et al. (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197, 12–24.
49 Serhan, CN, Chiang, N & Van Dyke, TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349–361.
50 Morris, MC, Sacks, F & Rosner, B (1993) Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523–533.
51 Yamagishi, K, Nettleton, JA & Folsom, AR (2008) Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156, 965–974.
52 Mozaffarian, D, Psaty, BM, Rimm, EB, et al. (2004) Fish intake and risk of incident atrial fibrillation. Circulation 110, 368–373.
53 Gillet, L, Roger, S, Bougnoux, P, et al. (2011) Beneficial effects of omega-3 long-chain fatty acids in breast cancer and cardiovascular diseases: voltage-gated sodium channels as a common feature? Biochimie 93, 4–6.
54 Saravanan, P, Bridgewater, B, West, AL, et al. (2010) Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 3, 46–53.
55 Brouwer, IA, Raitt, MH, Dullemeijer, C, et al. (2009) Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 30, 820–826.
56 Verkerk, AO, van Ginneken, AC, Berecki, G, et al. (2006) Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 70, 509–520.
57 Coronel, R, Wilms-Schopman, FJ, Den Ruijter, HM, et al. (2007) Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res 73, 386–394.
58 Wang, C, Harris, WS, Chung, M, et al. (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5–17.
59 Chalupka, S (2009) Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention. AAOHN J 57, 480.
60 Knapp, HR, Reilly, IA, Alessandrini, P, et al. (1986) In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 314, 937–942.
61 Kristensen, SD, Iversen, AM & Schmidt, EB (2001) n-3 polyunsaturated fatty acids and coronary thrombosis. Lipids 36, S79–S82.
62 Eritsland, J, Arnesen, H, Seljeflot, I, et al. (1995) Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 6, 17–22.
63 Watson, PD, Joy, PS, Nkonde, C, et al. (2009) Comparison of bleeding complications with omega-3 fatty acids+aspirin+clopidogrel–versus–aspirin+clopidogrel in patients with cardiovascular disease. Am J Cardiol 104, 1052–1054.
64 Park, K & Mozaffarian, D (2010) Omega-3 fatty acids, mercury, and selenium in fish and the risk of cardiovascular diseases. Curr Atheroscler Rep 12, 414–422.
65 Fremont, L, Gozzelino, MT, Franchi, MP, et al. (1998) Dietary flavonoids reduce lipid peroxidation in rats fed polyunsaturated or monounsaturated fat diets. J Nutr 128, 1495–1502.
66 Hau, MF, Smelt, AH, Bindels, AJ, et al. (1996) Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 16, 1197–1202.
67 Sorensen, NS, Marckmann, P, Hoy, CE, et al. (1998) Effect of fish-oil-enriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation. Am J Clin Nutr 68, 235–241.
68 Bonanome, A, Biasia, F, De Luca, M, et al. (1996) n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr 63, 261–266.
69 Brude, IR, Drevon, CA, Hjermann, I, et al. (1997) Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol 17, 2576–2588.
70 Higdon, JV, Du, SH, Lee, YS, et al. (2001) Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J Lipid Res 42, 407–418.
71 Petersson, H, Riserus, U, McMonagle, J, et al. (2010) Effects of dietary fat modification on oxidative stress and inflammatory markers in the LIPGENE study. Br J Nutr 104, 1357–1362.
72 Leaf, A, Kang, JX, Xiao, YF, et al. (2003) Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107, 2646–2652.
73 Leng, GC, Taylor, GS, Lee, AJ, et al. (1999) Essential fatty acids and cardiovascular disease: the Edinburgh Artery Study. Vasc Med 4, 219–226.